Brighthouse Financial, Inc. research snapshot

BHF AI Stock Analysis

BHF AI stock analysis currently reads Brighthouse Financial as a mid-cap life insurance and annuity company in a special-situation merger arbitrage driven by the pending Aquarian Holdings acquisition. At the August 4, 2026 data cutoff, the reference price was $62.16 as of August 3, 2026, with a verified market capitalization near $3.57 billion. The constructive case is a P/B of 0.52x to 0.64x, a large general account and in-force block, and the announced all-cash acquisition price of $4.1 billion, which implies about $71.37 per share against the verified share count. The caution is that the deal spread has widened to roughly 14.8% from about 7.6% in mid-July, TTM GAAP net income remains negative at about -$167 million, AM Best kept its under review with negative implications status on July 29, 2026, and short interest is still elevated near 9.3% to 9.5% of float. Q2 2026 results were scheduled for August 6 to 7, 2026, just after this data cutoff. This BHF AI stock analysis is informational research, not investment advice.

Current price

$62.16

Market cap

$3.57 billion

AI score

56 / 100

Rating

Special-situation merger arbitrage with a large discount to the announced acquisition price, offset by a widened deal spread and AM Best negative review

Trend status

Pulled back about 7% from the July 52-week high of $66.80 to $62.16, now below the 50-day moving average near $63.54 while holding just above the 200-day moving average near $61.95

Data cutoff (updated monthly)

August 4, 2026

Informational use only. This page is not investment advice.

Research quality check

information Richness
B-level information richness. Brighthouse Financial has SEC filings, earnings releases, analyst coverage from 10 firms, daily market data, and a clear pending-catalyst calendar, but its short public history (spun off from MetLife in 2017) and the pending acquisition reduce the length of useful operating and trading trends.
bias Check
The main AI bias risk is anchoring on the $4.1 billion Aquarian buyout price as a floor while under-weighting that the deal spread has widened to about 14.8%, the second consecutive AM Best update kept a negative review, and no close date has been confirmed. The short public trading history also limits the statistical reliability of trend analysis.
ai Confidence
High for current price, market-cap math, shares outstanding, book value bases, cash and debt totals, short interest, and analyst consensus figures, all cross-checked across MarketBeat, StockAnalysis.com, and Yahoo Finance during the August 4, 2026 refresh. Medium for forward scenarios because a pending acquisition makes organic earnings forecasts secondary until deal uncertainty resolves.
investment Certainty
Low to medium. BHF is defined by an announced buyout whose spread has widened. The investment outcome depends on deal completion, timing, and terms, not on organic business improvement. This is a merger-arbitrage scenario, not a classic long-term compounding story.

Quick verdict table

DimensionConclusionConfidence
Business qualityBrighthouse sells annuities and life insurance through independent distributors, generating premium-based revenue with a large in-force block and repeat policyholder premiums.Medium-high
MoatThe moat comes from regulatory licenses, the in-force policy block, distribution relationships, and the MetLife heritage brand. However, the annuity and life insurance market is competitive with low switching costs for new policies.Medium
ManagementCEO Eric Steigerwalt has led the post-spinoff strategy, capital return, and the Aquarian sale process. Stockholders approved the merger on February 12, 2026, but management has limited room to influence closing conditions or the widening deal spread.Medium
Financial trendFY 2025 revenue was about $6.77 billion with net income near $331 million and EPS near $5.71. Q1 2026 revenue declined 29.4% year over year, and TTM GAAP net income was negative at about -$167 million. Forward EPS estimates near $19.20 imply a recovery on adjusted operating metrics.Medium-high
ValuationAt $62.16, P/B is about 0.52x to 0.64x depending on the book value basis ($119.49 per MarketBeat, $96.85 per StockAnalysis), P/S is roughly 0.53x to 0.59x, and the stock trades well below the announced acquisition price of about $71.37 per share. Forward P/E near 3.0x to 3.3x signals expected normalized earnings recovery.Medium
Technical trendBHF pulled back from a 52-week high of $66.80 to $62.16 as of August 3, 2026. Price is below the 50-day moving average near $63.54 but above the 200-day moving average near $61.95. RSI near 37 signals fading momentum, and volume is below average.Medium-high
Risk levelKey risks are deal failure or repricing of the Aquarian acquisition, GAAP earnings volatility from actuarial assumptions and investment marks, insurance liability duration, interest rate sensitivity, and elevated short interest near 9.3% to 9.5% of float.Medium-high
AI confidenceHigh for current price, market-cap math, shares outstanding, book value bases, cash and debt totals, and analyst data, all cross-checked across MarketBeat, StockAnalysis.com, and Yahoo Finance. Medium for forward scenarios because organic earnings analysis is secondary to the acquisition outcome.High data confidence
Investment certaintyLow to medium. BHF is best understood as a special-situation merger-arbitrage position, not a classic long-term equity compounding story. The widened deal spread reflects real closing risk.Low-medium

BHF AI stock forecast

BHF AI Stock Forecast Scenarios

The BHF AI stock forecast centers on the announced Aquarian Holdings acquisition rather than organic earnings growth. The announced all-cash price of $4.1 billion implies about $71.37 per share based on the verified share count. At the August 4, 2026 cutoff price of $62.16, the deal spread is roughly 14.8%. These scenarios are not a reliable prediction of BHF stock price and assume the deal outcome, not organic growth, drives the stock.

Bullish case (deal closes)

$71 to $72

More likely if the Aquarian acquisition closes at the announced $4.1 billion price, regulatory approvals are obtained without material concessions, and the deal is completed without a repricing. The stock would converge toward the implied $71.37 per share price.

Base case (deal closes at revised terms)

$62 to $71

Represents a scenario where the acquisition closes but at a modestly adjusted price or on an extended timeline due to regulatory conditions, financing changes, or market conditions. The stock would trade near the adjusted offer price, keeping the current discount partially in place.

Bearish case (deal fails)

$45 to $55

More likely if the Aquarian acquisition is terminated, blocked by regulators, or re-priced materially lower. BHF would revert to trading as a standalone mid-cap life insurer with GAAP losses, declining revenue, and a P/B near or below current levels. The widened deal spread makes this scenario more probable than in mid-July.

BHF AI technical analysis

BHF AI Technical Analysis

BHF technical analysis as of August 3, 2026 shows a stock that rallied from October 2025 lows near $42 to a 52-week high of $66.80 in mid-July, then pulled back about 7% to the $62 area. Price now sits below the 50-day moving average near $63.54 while holding just above the 200-day moving average near $61.95, a neutral to cautious configuration for a deal-driven name. Key levels center on the announced buyout price and the July highs.

LevelValueWhy it matters
Resistance (R1)$71.37Implied Aquarian acquisition price at $4.1 billion against 57.45 million shares. Psychological ceiling unless the deal improves.
Resistance (R2)$66.8052-week high reached in mid-July 2026. A clean break above this level would signal renewed strength, but upside is capped near the deal price.
Support (S1)$61.91July 31, 2026 close and the 50-day range low. Also near the 200-day moving average of $61.95. A break below this zone would suggest deal-spread widening.
Support (S2)$57.00Round-number support zone below the 200-day moving average. A drop below this level would signal elevated deal-failure probability.
Support (S3)$52.87Pre-acquisition-announcement support level. Would likely be revisited only if the acquisition is definitively terminated.
Support (S4)$42.0752-week low. Would only be approached if the deal is terminated and standalone fundamentals deteriorate.
50-day MA$63.54Price is below the 50-day moving average, signaling a near-term pullback from the July high.
200-day MA$61.95Price is marginally above the 200-day moving average, keeping the medium-term uptrend from October 2025 intact for now.
RSI (14-day)37.3Momentum has faded from the July rally. Neutral to weak momentum is consistent with a pause in a deal-driven uptrend.
Volume~308K to 321K (below avg.)August 3, 2026 volume was below the 20-day average near 555K to 630K. Low volume during the pullback suggests limited panic selling.

BHF AI trading strategy

BHF AI Trading Strategy Framework

BHF is primarily a merger-arbitrage situation. A conventional trend-following or mean-reversion strategy is less relevant than a deal-contingent framework. The trading strategy below reflects this special-situation context rather than a standard equity approach. Always do your own due diligence.

Merger-arbitrage framework

The primary strategy is to capture the remaining spread between the current price ($62.16) and the announced acquisition price of about $71.37 per share, currently roughly 14.8%. The annualized return depends on the expected deal closing date. Monitor regulatory filings, Aquarian financing, and the timing of the first closing window after the February 2026 stockholder approval.

The main risk is deal failure, which the widened spread reflects. Position size should match the binary nature of this event. Use a stop-loss if the stock breaks below $61.90 or if negative deal news emerges. Do not add to the position if the spread widens without confirmed deal-progress news.

Trend-following framework

If trading BHF as a long equity position rather than a merger-arbitrage play, wait for a reclaim of the 50-day moving average near $63.54 with a target near the 52-week high of $66.80. Use a trailing stop of 5% to 7% below entry and avoid adding on strength above $66.80 given the deal-price ceiling.

Set an invalidation stop near $61.50, below both the 200-day moving average and the $61.91 recent support. Reduce exposure if the 200-day MA near $61.95 is breached. Avoid holding through any announced regulatory delay.

Mean-reversion framework

BHF has low daily volatility relative to small-cap insurers. In the current deal-driven environment, mean reversion near the $61.90 to $62.00 support zone into the $64 to $65 area is possible, but the trade is secondary to the deal catalyst and the gap risk is high.

Keep position size small. Exit immediately if the stock gaps down on acquisition news. This framework is only relevant while the stock remains in the $61.90 to $66.80 range.

Investment research summary

Four-master Research Compression

Business essence

Brighthouse Financial sells annuities and life insurance products to U.S. consumers through independent distribution channels. Customers pay premiums for retirement income guarantees, death benefits, and protected wealth accumulation. The company earns spread income and fee-based revenue on a large in-force block of policies inherited from MetLife.

Moat

The moat is moderate and rests on regulatory licenses, the in-force policy block which provides recurring premium income, and MetLife-origin brand recognition. Switching costs exist for in-force policyholders but are low for new policy purchases. The annuity market is competitive with players like MetLife, Equitable, Jackson Financial, and Fidelity & Guaranty.

Munger risk inversion

The thesis fails if the Aquarian acquisition is terminated or re-priced materially lower. The deal spread widening to about 14.8% and AM Best maintaining its under review with negative implications status on July 29, 2026 are the clearest warnings. Other failure paths include adverse reserve development on the legacy block, investment losses in the general account, policy lapses exceeding assumptions, or a prolonged low-interest-rate environment that compresses spread income.

Management

CEO Eric Steigerwalt has led BHF since the 2017 MetLife spinoff through capital optimization, expense management, and the Aquarian sale process. Stockholders approved the merger on February 12, 2026. The board and management have pursued a definitive sale as the primary shareholder-value path. Key-person risk is moderate if the deal closes and management departs post-acquisition.

Industry trend

The U.S. life and annuity industry benefits from structural demand driven by Baby Boomer retirement, employer retirement plan growth, and protected-income product adoption. However, Reuters reported on April 27, 2026 that short sellers doubled their bets against U.S. life insurance stocks to over $5 billion, partly on private credit concerns. The sector faces regulatory change, low organic growth, and competition from alternative retirement solutions.

Valuation and margin of safety

At $62.16 with book value per share near $96.85 (StockAnalysis) or $119.49 (MarketBeat), BHF trades at 0.52x to 0.64x book, a discount to life-insurer peers. The announced $4.1 billion buyout at about $71.37 per share represents roughly 14.8% upside to the current price. The margin of safety depends on deal completion. If the deal fails, the stock could trade down to the $45 to $55 range, implying material downside.

Source-backed data

BHF Data Table

Every metric below includes a source and last verification date.

MetricValueSourceLast verified
Current stock price$62.16MarketBeat / StockAnalysis.comAugust 3, 2026
Market capitalization$3.57 billionMarketBeat / StockAnalysis.com / Yahoo FinanceAugust 3, 2026
Enterprise value$8.62 billion (StockAnalysis) / $6.46 billion (Yahoo)StockAnalysis.com / Yahoo FinanceAugust 3, 2026
Book value per share$96.85 (StockAnalysis) / $119.49 (MarketBeat)StockAnalysis.com / MarketBeatAugust 3, 2026
Price to book ratio0.52x to 0.64xMarketBeat / StockAnalysis.com / financial_rigor.pyAugust 3, 2026
TTM GAAP EPS-$2.93 to -$3.07StockAnalysis.com / Yahoo FinanceAugust 3, 2026
Forward P/E ratio3.0x to 3.3x (implied forward EPS ~$19.20)MarketBeat / StockAnalysis.com / Yahoo FinanceAugust 3, 2026
Total cash$6.97 billionStockAnalysis.com / Yahoo FinanceAugust 3, 2026
Total debt$9.92 billionStockAnalysis.comAugust 3, 2026
Net cash position-$5.02 billion (-$87.33 per share)StockAnalysis.comAugust 3, 2026
Debt to equity ratio176.33% (Yahoo) / 1.76 (StockAnalysis)Yahoo Finance / StockAnalysis.comAugust 3, 2026
FY 2025 annual revenue$6.77 billionMarketBeat / StockAnalysis.com financialsAugust 3, 2026
FY 2025 net income / EPS$331 million / $5.71StockAnalysis.com financialsAugust 3, 2026
Q1 2026 revenueDown 29.4% year over yearMarketBeat / company earnings release May 6, 2026August 3, 2026
Q1 2026 GAAP EPS$4.35 (missed consensus)MarketBeat / Zacks ResearchAugust 3, 2026
52-week range$42.07 to $66.80MarketBeat / StockAnalysis.com / Yahoo FinanceAugust 3, 2026
Beta (5-year monthly)0.86 to 0.87StockAnalysis.com / Yahoo FinanceAugust 3, 2026
Shares outstanding57.45 millionMarketBeat / StockAnalysis.comAugust 3, 2026
Short interest (% of float)9.33% to 9.48% (10.6 to 10.8 days to cover)MarketBeat / StockAnalysis.comAugust 3, 2026
Institutional ownership81.24% (MarketBeat) / 94.24% (StockAnalysis)MarketBeat / StockAnalysis.comAugust 3, 2026
Analyst consensusReduce (1.80 / 4.0, MarketBeat) / Hold (StockAnalysis)MarketBeat / StockAnalysis.comAugust 3, 2026
Average analyst price target$60.50 (range: $53-$70) per MarketBeat; $65.00 per StockAnalysis/YahooMarketBeat / StockAnalysis.com / Yahoo FinanceAugust 3, 2026
Announced acquisition price$4.1 billion (~$71.37/share)Reuters / SEC filings / financial_rigor.pyAugust 3, 2026
Stockholder approval of mergerApproved February 12, 2026Business WireAugust 3, 2026
AM Best rating statusA (Excellent) FSR and a+ Long-Term ICR, under review with negative implications since Nov 10, 2025, maintained July 29, 2026AM Best / Business WireAugust 3, 2026
Next earnings dateEstimated August 6-7, 2026MarketBeat / StockAnalysis.com / Yahoo FinanceAugust 3, 2026

Frequently Asked Questions

This BHF AI stock analysis page is for informational and educational purposes only. It does not constitute investment advice, a recommendation to buy or sell securities, or a solicitation of any kind. All data, forecasts, scenarios, and technical levels are based on publicly available information as of the data cutoff date (August 4, 2026) and may change without notice. Past performance is not indicative of future results. Investing in equities involves risk, including the potential loss of principal. The analysis uses AI-assisted research and should not be relied upon as the sole basis for an investment decision. Please consult a qualified financial advisor before making any investment.